科伦药业前三季度净利12.01亿元，同比下降51.41%

Core Insights - Kolun Pharmaceutical reported a decline in both revenue and net profit for the first three quarters of 2025 [1] Financial Performance - The company's operating revenue for the first three quarters was 13.277 billion yuan, representing a year-on-year decrease of 20.92% [1] - The net profit attributable to shareholders was 1.201 billion yuan, showing a year-on-year decline of 51.41% [1]